NIHR Signal: Iron deficiency in people with chronic kidney disease can be managed with either oral or IV therapy

Expert commentary is provided for a review of 39 RCTs (n=3,852) which found that death and cardiovascular death rates were not different for IV and oral iron. Questions remain about cost-effectiveness and tolerability of both oral and IV therapies.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news